You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 10, 2025

Drug Price Trends for NDC 20536-0322


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 20536-0322

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
MARQIBO KIT 5MG/31ML Acrotech Biopharma LLC 20536-0322-01 31ML 11002.60 354.92258 2020-02-15 - 2025-02-14 FSS
MARQIBO KIT 5MG/31ML Acrotech Biopharma LLC 20536-0322-01 31ML 11153.34 359.78516 2021-01-01 - 2025-02-14 FSS
MARQIBO KIT 5MG/31ML Acrotech Biopharma LLC 20536-0322-01 31ML 11754.50 379.17742 2022-01-01 - 2025-02-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

20536-0322 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 20536-0322

Understanding NDCs

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what an NDC is. The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code[1][4].

Identifying the Drug

The NDC 20536-0322 corresponds to a specific drug product. However, without specific details on the drug name, we need to rely on general principles of market analysis and price projections.

Market Analysis

Pharmaceutical Market Trends

The pharmaceutical market is influenced by several factors, including regulatory changes, technological advancements, and economic conditions. For instance, the rise of immunotherapies and targeted therapies has significantly impacted the market for certain diseases, such as non-small cell lung cancer (NSCLC)[3].

Drug Pricing Transparency

Drug pricing is a complex issue, with prices influenced by various entities in the pharmaceutical supply chain, including manufacturers, pharmacy benefit managers (PBMs), and health insurers. Transparency programs, like the one in Oregon, aim to monitor and report price increases and other cost factors to help contain costs[2].

Price Projections

General Trends

  • Price Inflation: The pharmaceutical industry is expected to see a general increase in prices due to inflation. For example, a projected 3.81% drug price inflation rate is anticipated[5].
  • Market Competition: The presence of generic and biosimilar drugs can significantly impact the pricing of branded drugs. For instance, the introduction of biosimilar bevacizumab is expected to reduce the market share and price of branded Avastin[3].

Specific Drug Pricing

Without specific data on the drug associated with NDC 20536-0322, we can look at general trends:

  • Brand Name Drugs: These often see significant price increases, with median increases reported around 13.4% in some studies[2].
  • Generic Drugs: While generally cheaper, generic drugs can also experience substantial price hikes, with some examples showing increases as high as 2,527% over a few years[2].

Factors Influencing Price Projections

Regulatory Oversight

Regulatory changes and oversight can significantly impact drug pricing. For example, the implementation of upper payment limits or bulk purchasing models can reduce costs for consumers and payers[2].

Market Demand and Supply

The demand for a drug, driven by its efficacy, safety, and market positioning, can influence its price. Additionally, supply chain disruptions or changes in manufacturing costs can also affect pricing.

Technological Advancements

New technologies and treatments can shift market dynamics. For instance, the increasing use of immunotherapies in NSCLC has driven significant market growth and pricing changes[3].

Case Study: Similar Drugs

To make an educated guess about the price projections for NDC 20536-0322, let's consider a similar drug:

  • MULPLETA (NDC 59630-0551): This drug has seen price changes over time, with prices per unit increasing from $908.69 to $1,195.98 between different pricing types and dates[5].

Key Takeaways

  • Price Inflation: Expect a general increase in drug prices due to inflation.
  • Regulatory Impact: Changes in regulatory oversight and transparency programs can influence pricing.
  • Market Competition: The presence of generics and biosimilars can reduce prices of branded drugs.
  • Technological Advancements: New treatments and technologies can drive market growth and pricing changes.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique, three-segment number that identifies a drug product, including the labeler code, product code, and package code[1][4].
  2. How do regulatory changes impact drug pricing?

    • Regulatory changes, such as the implementation of upper payment limits or bulk purchasing models, can reduce costs for consumers and payers[2].
  3. What role do generics and biosimilars play in drug pricing?

    • Generics and biosimilars can significantly reduce the prices of branded drugs by increasing competition[3].
  4. How does market demand influence drug pricing?

    • High demand for a drug, driven by its efficacy and market positioning, can increase its price[3].
  5. What is the impact of technological advancements on drug pricing?

    • New technologies and treatments can drive market growth and pricing changes, as seen in the rise of immunotherapies in NSCLC[3].

Sources

  1. NDC Directory - YouTube
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon Drug Price Transparency Program
  3. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
  4. National Drug Code Directory - FDA
  5. Latest drug prices and trends for NDC 59630-0551 - DrugPatentWatch

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.